Stock Analysts’ updated eps estimates for Thursday, August 10th:

Advanced Micro Devices (NASDAQ:AMD) had its underweight rating reiterated by analysts at Barclays PLC. Barclays PLC currently has a $9.00 target price on the stock.

StoneCastle Financial Corp (NASDAQ:BANX) had its buy rating reaffirmed by analysts at Keefe, Bruyette & Woods. Keefe, Bruyette & Woods currently has a $22.50 target price on the stock.

Bridge Bancorp (NASDAQ:BDGE) had its hold rating reiterated by analysts at Keefe, Bruyette & Woods. They currently have a $37.00 price target on the stock.

Benefitfocus (NASDAQ:BNFT) had its buy rating reissued by analysts at Berenberg Bank. They currently have a $36.00 price target on the stock.

Capital Trust (NYSE:BXMT) had its buy rating reaffirmed by analysts at Keefe, Bruyette & Woods. Keefe, Bruyette & Woods currently has a $33.00 target price on the stock.

Chemical Financial Corporation (NASDAQ:CHFC) had its buy rating reissued by analysts at Keefe, Bruyette & Woods. Keefe, Bruyette & Woods currently has a $54.00 price target on the stock.

Clovis Oncology (NASDAQ:CLVS) had its overweight rating reiterated by analysts at Morgan Stanley. Morgan Stanley currently has a $93.00 target price on the stock.

Charles Taylor PLC (LON:CTR) had its buy rating reissued by analysts at Liberum Capital. Liberum Capital currently has a GBX 280 ($3.65) price target on the stock.

Direct Line Insurance Group PLC (LON:DLG) had its price target boosted by HSBC Holdings plc from GBX 372 ($4.84) to GBX 440 ($5.73). The firm currently has a buy rating on the stock.

Deutsche Telekom AG (FRA:DTE) was given a €21.00 ($24.71) price target by analysts at Barclays PLC. The firm currently has a buy rating on the stock.

Encore Capital Group (NASDAQ:ECPG) had its buy rating reissued by analysts at Keefe, Bruyette & Woods. They currently have a $49.50 price target on the stock.

Editas Medicine (NASDAQ:EDIT) had its hold rating reissued by analysts at Cann. The analysts wrote, “Editas’ loss per share was $0.65, compared to our estimated loss of $1.01. This was the result of higher than expected collaborative revenue, lower than estimated operating expenses and higher than estimated shares outstanding.””

Enterprise Products Partners L.P. (NYSE:EPD) had its outperform rating reiterated by analysts at Sanford C. Bernstein.

Esperion Therapeutics (NASDAQ:ESPR) had its buy rating reaffirmed by analysts at Stifel Nicolaus. The firm currently has a $70.00 target price on the stock, up from their previous target price of $60.00.

Energy Transfer Equity, L.P. (NYSE:ETE) had its outperform rating reiterated by analysts at Sanford C. Bernstein.

Evonik Industries AG (FRA:EVK) was given a €25.00 ($29.41) target price by analysts at J P Morgan Chase & Co. The firm currently has a sell rating on the stock.

easyJet plc (LON:EZJ) had its hold rating reiterated by analysts at Deutsche Bank AG. They currently have a GBX 1,310 ($17.06) price target on the stock.

First Commonwealth Financial Corporation (NYSE:FCF) had its hold rating reissued by analysts at Keefe, Bruyette & Woods. They currently have a $14.00 price target on the stock.

First Data Corporation (NYSE:FDC) had its overweight rating reiterated by analysts at Piper Jaffray Companies. They currently have a $23.00 price target on the stock, up from their previous price target of $22.00.

Flushing Financial Corporation (NASDAQ:FFIC) had its hold rating reiterated by analysts at Keefe, Bruyette & Woods. They currently have a $30.00 price target on the stock.

freenet AG (FRA:FNTN) was given a €36.00 ($42.35) target price by analysts at equinet AG. The firm currently has a buy rating on the stock.

Fiesta Restaurant Group (NASDAQ:FRGI) had its neutral rating reaffirmed by analysts at Piper Jaffray Companies. They currently have a $17.00 price target on the stock, down from their previous price target of $22.00.

GW Pharmaceuticals PLC (NASDAQ:GWPH) had its outperform rating reiterated by analysts at Leerink Swann. Leerink Swann currently has a $160.00 price target on the stock, down from their previous price target of $162.00.

Hastings Group Hldg PLC (LON:HSTG) had its equal weight rating reaffirmed by analysts at Barclays PLC.

Horizon Pharma PLC (NASDAQ:HZNP) had its outperform rating reaffirmed by analysts at BMO Capital Markets. The firm currently has a $18.00 target price on the stock, up from their previous target price of $17.00.

International Consolidated Airlns Grp SA (LON:IAG) had its buy rating reissued by analysts at Deutsche Bank AG. They currently have a GBX 680 ($8.86) price target on the stock.

Invesco Mortgage Capital (NYSE:IVR) had its buy rating reiterated by analysts at Keefe, Bruyette & Woods. The firm currently has a $18.25 price target on the stock.

Jenoptik AG (ETR:JEN) was given a €22.00 ($25.88) target price by analysts at Baader Bank. The firm currently has a neutral rating on the stock.

Kura Oncology (NASDAQ:KURA) had its outperform rating reaffirmed by analysts at Leerink Swann. They currently have a $18.00 price target on the stock, up from their previous price target of $16.00.

LendingClub Corporation (NYSE:LC) had its neutral rating reissued by analysts at Credit Suisse Group. Credit Suisse Group currently has a $8.00 price target on the stock.

LendingClub Corporation (NYSE:LC) had its hold rating reissued by analysts at Canaccord Genuity. Canaccord Genuity currently has a $7.00 price target on the stock.

Legal & General Group Plc (LON:LGEN) had its overweight rating reissued by analysts at Barclays PLC.

Deutsche Lufthansa AG (ETR:LHA) was given a €19.70 ($23.18) price target by analysts at Deutsche Bank AG. The firm currently has a neutral rating on the stock.

NeuroDerm (NASDAQ:NDRM) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Neuroderm Ltd. is a clinical-stage pharmaceutical company. It is developing next-generation treatments for central nervous system (CNS) disorders. The Company develops liquid levodopa (LD), which is a treatment for Parkinson’s disease (PD). Its product pipelines includes ND0612L for moderate PD, ND0612H for severe PD, ND0680 for severe PD, ND0701 for severe PD and ND0801for Cognitive Disorders. NeuroDerm Ltd. is headquartered in Rehovot, Israel. “

Netflix (NASDAQ:NFLX) had its hold rating reiterated by analysts at Jefferies Group LLC.

Natural Gas Services Group (NYSE:NGS) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Natural Gas Services Group, Inc. manufactures, fabricates, sells, rents and services natural gas compressors that enhance the production of natural gas wells. The Company also manufactures and sells flare systems and flare ignition systems for plant and production facilities. “

NVIDIA Corporation (NASDAQ:NVDA) had its underperform rating reaffirmed by analysts at BMO Capital Markets. BMO Capital Markets currently has a $85.00 target price on the stock.

NVIDIA Corporation (NASDAQ:NVDA) had its buy rating reiterated by analysts at Rosenblatt Securities. The firm currently has a $152.00 target price on the stock.

Southwest Bancorp (NASDAQ:OKSB) had its hold rating reiterated by analysts at Keefe, Bruyette & Woods. Keefe, Bruyette & Woods currently has a $29.00 target price on the stock.

Patrizia Immobilien (SWX:P1Z) was given a €22.00 ($25.88) target price by analysts at equinet AG. The firm currently has a buy rating on the stock.

Radware (NASDAQ:RDWR) had its outperform rating reiterated by analysts at Imperial Capital. Imperial Capital currently has a $21.00 price target on the stock, up from their previous price target of $20.00.

Realogy Holdings Corp. (NYSE:RLGY) had its buy rating reaffirmed by analysts at Keefe, Bruyette & Woods. They currently have a $38.00 price target on the stock.

Sunrun (NASDAQ:RUN) had its neutral rating reissued by analysts at Bank of America Corporation. Bank of America Corporation currently has a $8.00 price target on the stock, up from their previous price target of $7.75.

Synergy Pharmaceuticals (NASDAQ:SGYP) had its buy rating reissued by analysts at Cantor Fitzgerald. They currently have a $11.00 target price on the stock. The analysts wrote, “Management upbeat about early returns. SGYP reported 2Q17 results and posted a new corporate presentation to provide an update of the Trulance launch (here). We spoke with management (no results call was held) to hear its views regarding how the launch is proceeding. Acknowledging the inherent positive bias of company managements that have launched their inaugural product, we believe metrics provided by SGYP may, however, show an objective snapshot of the launch.””

Synthomer PLC (LON:SYNT) had its overweight rating reiterated by analysts at Barclays PLC.

Textainer Group Holdings Limited (NYSE:TGH) had its hold rating reiterated by analysts at Keefe, Bruyette & Woods. They currently have a $16.00 price target on the stock.

Tenet Healthcare Corporation (NYSE:THC) had its outperform rating reaffirmed by analysts at Robert W. Baird. They currently have a $23.00 target price on the stock.

Triton International Limited (NASDAQ:TRTN) had its hold rating reiterated by analysts at Keefe, Bruyette & Woods. Keefe, Bruyette & Woods currently has a $35.00 price target on the stock.

Tyson Foods (NYSE:TSN) had its outperform rating reiterated by analysts at BMO Capital Markets. They currently have a $78.00 price target on the stock, up from their previous price target of $75.00.

TESARO (NASDAQ:TSRO) had its overweight rating reissued by analysts at Morgan Stanley. They currently have a $183.00 price target on the stock.

2U (NASDAQ:TWOU) had its outperform rating reissued by analysts at BMO Capital Markets. The firm currently has a $56.00 price target on the stock, up from their previous price target of $54.00.

Virtusa Corporation (NASDAQ:VRTU) had its buy rating reissued by analysts at Needham & Company LLC. The firm currently has a $38.00 price target on the stock.

Wayfair (NYSE:W) had its buy rating reissued by analysts at Buckingham Research. Buckingham Research currently has a $95.00 target price on the stock.

Williams Companies, Inc. (The) (NYSE:WMB) had its outperform rating reiterated by analysts at Sanford C. Bernstein.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.